A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success kblankenship Wed, 06/17/2020 […]
Category: Uncategorized
Takeda blasted again for particle contamination months after Natpara recall kblankenship Wed, 06/17/2020 – 09:01
Merck’s Keytruda nabs 2nd biomarker-driven FDA nod, regardless of tumor type aliu Wed, 06/17/2020 – 09:20
Is dexamethasone really a COVID-19 breakthrough? Not so fast, doctors say arlene.weintraub Wed, 06/17/2020 – 09:22
Novavax, advancing COVID-19 shot, recruits AstraZeneca exec as its chief medical officer esagonowsky Wed, 06/17/2020 – 10:06
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of […]
Conventional melanoma therapies, including chemotherapy and radiotherapy, suffer from the toxicity and side effects of repeated treatments due […]
The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised […]
The deal gives GSK access to IDEAYA’s MAT2A, Pol Theta, and Werner Helicase programmes